Apollomics, Inc. rose 17.6% on Tuesday, November 10, 2026, on 11,113 shares. No headline about APLMW came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Apollomics, Inc. (APLMW:NASDAQ) closed at $0.010 on November 13, 2026, unchanged on the day. It is trading at its 52-week low of $0.010. Apollomics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, APLMW closed higher on 30 days (12%). Its best day was June 30, 2026 (+142.17%) and its worst was March 6, 2026 (-50.00%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 71 times.
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.
Find more stocks like APLMW with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.